Pancreatic Cancer Research

ResearcherKarolinska University HospitalActive in the last 2 years

Wen‐Kuan Huang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-7789-8347; OpenAlex author ID A5025201951. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
4
Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: none · 2023: none · 2024: 1 paper

Papers 3

  1. Efficacy of first-line combination therapies versus gemcitabine monotherapy for advanced pancreatic cancer: a systematic review and network meta-analysis. Co-author DOI 10.62347/tqrb4608↗
  2. ARHGAP25 Inhibits Pancreatic Adenocarcinoma Growth by Suppressing Glycolysis via AKT/mTOR Pathway. Co-author DOI 10.7150/ijbs.55919↗
  3. Concurrent chemoradiotherapy with or without induction chemotherapy versus chemotherapy alone in patients with locally advanced pancreatic cancer. Co-author PMID 25368287↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Shuijie Li · 1 shared paper, 2021 · strength 0.14
  2. Chun‐Nan Yeh · 1 shared paper, 2021 · strength 0.14
  3. Jen‐Shi Chen · 1 shared paper, 2014 · strength 0.04
  4. Wen‐Chi Chou · 1 shared paper, 2014 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.